• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Science and Engineering Laboratories (OSEL) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118594
Nov 20118593
Dec 20118596
Jan 20128595
Feb 20128596
Mar 20128595
Apr 20128593
May 20128594
Jun 20128593
Jul 20128595
Aug 20128597
Sep 20128593

FY 2012 Overall: 95%

Number of OSEL intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A160
Nov 2011N/A147
Dec 2011N/A135
Jan 2012N/A130
Feb 2012N/A152
Mar 2012N/A150
Apr 2012N/A171
May 2012N/A158
Jun 2012N/A137
Jul 2012N/A184
Aug 2012N/A228
Sep 2012N/A149

FY 2012 Total: 1,901

Total number of OSEL intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A170
Nov 2011N/A158
Dec 2011N/A141
Jan 2012N/A137
Feb 2012N/A158
Mar 2012N/A158
Apr 2012N/A183
May 2012N/A168
Jun 2012N/A147
Jul 2012N/A194
Aug 2012N/A235
Sep 2012N/A161

FY 2012 Total: 2,010

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.